Home › Trial NCT03047616
A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer
- Trial IDNCT03047616
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorAbramson Cancer Center at Penn Medicine
- Enrollment88
- Start date2016-11-22
- ConditionsLung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.